Healthcare conglomerate Johnson & Johnson kicked off its bankruptcy plan confirmation Tuesday, in its third attempt to ...
Johnson & Johnson begins battle over $10 billion case linking baby powder to cancer - Courts have rejected J&J’s two previous ...
Johnson & Johnson (JNJ) begins on Tuesday its third attempt to push through a multi-billion-dollar settlement relating to ...
In a report released yesterday, Shagun Singh Chadha from RBC Capital initiated coverage with a Buy rating on Johnson & Johnson (JNJ – ...
Our clients are passing away,” attorney James Onder told US Bankruptcy Judge Christopher Lopez on Tuesday, the start of a ...
Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...
The fund owned 13,249 shares of the company’s stock after selling 800 shares during the period. Jmac Enterprises LLC’s holdings in Johnson & Johnson were worth $1,916,000 as of its most recent ...
Check Out Our Latest Report on Johnson & Johnson Johnson & Johnson Stock Down 0.7 % NYSE JNJ opened at $156.20 on Friday. The company has a quick ratio of 0.79, a current ratio of 1.03 and a debt ...
Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ...
A class action filed today says Kiwis have been deceived for about two decades through the use of phenylephrine in cold and ...
Johnson & Johnson introduces TECNIS PureSee IOL for presbyopia in India, offering high-quality vision and reduced visual ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results